Julien Rongère

Consigliere Generale presso AC IMMUNE SA

47 anni

Health Technology

Consumer Services

Profilo

Julien Rongère is currently working as the VP-Regulatory Affairs & Quality Assurance at AC Immune SA. Previously, he worked as the Director-Regulatory Affairs at Celgene Switzerland SARL and as a Regulatory Expert at Apoxis SA. Dr. Rongère holds a graduate degree from the University of Aberdeen and a doctorate degree from the University of Lausanne.

Posizioni attive di Julien Rongère

Società	Posizione	Inizio
AC IMMUNE SA	Consigliere Generale	01/07/2017

Tutte le posizioni attive di Julien Rongère

Precedenti posizioni note di Julien Rongère

Società	Posizione	Fine
Apoxis SA Apoxis SA Pharmaceuticals: MajorHealth Technology Apoxis SA develops therapeutics for the treatment of cancer and immunological diseases based on the mechanisms underlying apoptosis or cell death. The company particularly focuses on diseases with unmet medical needs and high commercial potential. It's lead product, APO866, is a novel small molecule therapeutic for the treatment of a range of cancers. The product is also being evaluated in a range of cancers in combination with commonly used chemo and radiotherapies in preclinical studies. It's oncology portfolio also includes APO010, a protein therapeutic that was developed using the company’s proprietary multimerization technology. The company is headquartered in Lausanne, Switzerland.	Corporate Officer/Principal	-
Celgene Switzerland SARL Celgene Switzerland SARL Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Switzerland SARL is a Swiss biopharmaceutical company. The company is based in Boudry, Switzerland.	Consigliere Generale	-

Vedi nel dettaglio l'esperienza di Julien Rongère

Formazione di Julien Rongère

University of Aberdeen	Graduate Degree
University of Lausanne	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Julien Rongère

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
AC IMMUNE SA	Health Technology

Aziende private	2
Celgene Switzerland SARL Celgene Switzerland SARL Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Switzerland SARL is a Swiss biopharmaceutical company. The company is based in Boudry, Switzerland.	Health Technology
Apoxis SA Apoxis SA Pharmaceuticals: MajorHealth Technology Apoxis SA develops therapeutics for the treatment of cancer and immunological diseases based on the mechanisms underlying apoptosis or cell death. The company particularly focuses on diseases with unmet medical needs and high commercial potential. It's lead product, APO866, is a novel small molecule therapeutic for the treatment of a range of cancers. The product is also being evaluated in a range of cancers in combination with commonly used chemo and radiotherapies in preclinical studies. It's oncology portfolio also includes APO010, a protein therapeutic that was developed using the company’s proprietary multimerization technology. The company is headquartered in Lausanne, Switzerland.	Health Technology